These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6982091)

  • 1. Comparison of the vasodilator action of dopamine and dopamine agonists in the renal and coronary beds of the dog.
    Lang WJ; Woodman OL
    Br J Pharmacol; 1982 Sep; 77(1):23-8. PubMed ID: 6982091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the responses to some dopamine-receptor agonists and antagonists in the isolated perfused rat kidney.
    Woodman OL; Rechtman MP; Lang WJ
    Arch Int Pharmacodyn Ther; 1980 Dec; 248(2):203-11. PubMed ID: 6971630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal vascular activity of SK&F 38393 and dopamine in anesthetized dogs.
    Hahn RA; Wardell JR
    J Cardiovasc Pharmacol; 1980; 2(5):583-93. PubMed ID: 6157951
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of the effects of fenoldopam, SK & F R-87516 and dopamine on renal arterioles in vitro.
    Edwards RM
    Eur J Pharmacol; 1986 Jul; 126(1-2):167-70. PubMed ID: 2875883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the peripheral and central effects of SK&F 82526, a novel dopamine receptor agonist.
    Hahn RA; Wardell JR; Sarau HM; Ridley PT
    J Pharmacol Exp Ther; 1982 Nov; 223(2):305-13. PubMed ID: 6127401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absence of postsynaptic DA2 dopamine receptors in the dog renal vasculature.
    Horn PT; Kohli JD
    Eur J Pharmacol; 1991 May; 197(2-3):125-30. PubMed ID: 1680707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of fenoldopam prodrugs with prolonged renal vasodilator activity.
    Brooks DP; DePalma PD; Cyronak MJ; Bryant MA; Karpinski K; Mico B; Gaitanopoulos DE; Chambers PA; Erhard KF; Weinstock J
    J Pharmacol Exp Ther; 1990 Sep; 254(3):1084-9. PubMed ID: 1975620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the hemodynamic activities of fenoldopam and its enantiomers in the dog.
    Kinter LB; Horner E; Mann WA; Weinstock J; Ruffolo RR
    Chirality; 1990; 2(4):219-25. PubMed ID: 1982058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of SK&F R-105058 and R-106114, N-ethyl carbamate ester prodrugs of fenoldopam.
    Brooks DP; DePalma PD; Cyronak MJ; Karpinski K; Weinstock J
    Pharmacology; 1990; 41(5):299-308. PubMed ID: 1982634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of specific dopamine-1 receptor-mediated coronary vasodilation in the anesthetized dog.
    Kopia GA; Valocik RE
    J Pharmacol Exp Ther; 1989 Jan; 248(1):215-21. PubMed ID: 2563287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasodilator response to dopamine in the ferret pulmonary circulation.
    Gorman P
    Br J Pharmacol; 1988 May; 94(1):212-8. PubMed ID: 2900036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dopaminergic agonists and antagonists on the partially contracted, isolated and perfused renal artery of the rat.
    Rodriguez-Mendez SA; Feria M; Boada J
    Pharmacology; 1986; 32(6):321-5. PubMed ID: 3487804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effects of the novel inotropic agent, ibopamine, with epinine, dopamine and fenoldopam on renal vascular dopamine receptors in the anesthetized dog.
    Nichols AJ; Smith JM; Shebuski RJ; Ruffolo RR
    J Pharmacol Exp Ther; 1987 Aug; 242(2):573-8. PubMed ID: 2886644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and renal vasodilator activity of 2-chlorodopamine and N-substituted derivatives.
    McCarthy JR; McCowan J; Zimmerman MB; Wenger MA; Emmert LW
    J Med Chem; 1986 Sep; 29(9):1586-90. PubMed ID: 3528490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence against a role for dopamine D1 receptors in the myocardium of the pig.
    Van Woerkens LJ; Duncker DJ; Den Boer MO; McFalls EO; Sassen LM; Saxena PR; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):246-50. PubMed ID: 1686206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topographical resolution of jaw movements mediated by cyclase- vs. non-cyclase-coupled dopamine D(1)-like receptors: studies with SK&F 83822.
    Fujita S; Lee J; Kiguchi M; Uchida T; Cools AR; Waddington JL; Koshikawa N
    Eur J Pharmacol; 2006 May; 538(1-3):94-100. PubMed ID: 16682023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and renal vasodilator activity of some dopamine agonist 1-aryl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diols: halogen and methyl analogues of fenoldopam.
    Weinstock J; Ladd DL; Wilson JW; Brush CK; Yim NC; Gallagher G; McCarthy ME; Silvestri J; Sarau HM; Flaim KE
    J Med Chem; 1986 Nov; 29(11):2315-25. PubMed ID: 2878077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic activity of substituted 6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepines.
    Pfeiffer FR; Wilson JW; Weinstock J; Kuo GY; Chambers PA; Holden KG; Hahn RA; Wardell JR; Tobia AJ; Setler PE; Sarau HM
    J Med Chem; 1982 Apr; 25(4):352-8. PubMed ID: 7069713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dopamine receptor agonists and antagonists at peripheral neuronal and vascular dopamine receptors in the anaesthetised dog.
    Hilditch A; Drew GM
    J Cardiovasc Pharmacol; 1984; 6(3):460-9. PubMed ID: 6202973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dopamine on ATP-sensitive potassium channels in porcine coronary artery smooth-muscle cells.
    Kawano H; Kawano T; Tanaka K; Eguchi S; Takahashi A; Nakaya Y; Oshita S
    J Cardiovasc Pharmacol; 2008 Feb; 51(2):196-201. PubMed ID: 18287888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.